comparemela.com

Latest Breaking News On - Bausch health companies price performance - Page 1 : comparemela.com

Redwood Investment Management LLC Boosts Stock Holdings in Bausch Health Companies Inc (NYSE:BHC)

Redwood Investment Management LLC increased its position in shares of Bausch Health Companies Inc. (NYSE:BHC – Free Report) by 3.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 401,495 shares of the company’s stock after purchasing an additional 14,184 shares during the quarter. Redwood Investment Management […]

Crestline Management LP Takes $16 04 Million Position in Bausch Health Companies Inc (NYSE:BHC)

Crestline Management LP bought a new position in Bausch Health Companies Inc. (NYSE:BHC – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 2,000,000 shares of the company’s stock, valued at approximately $16,040,000. Bausch Health Companies makes up approximately 1.4% of Crestline Management LP’s investment […]

Zacks Research Comments on Bausch Health Companies Inc s Q2 2024 Earnings (NYSE:BHC)

Bausch Health Companies Inc. (NYSE:BHC – Free Report) – Analysts at Zacks Research lowered their Q2 2024 earnings per share (EPS) estimates for shares of Bausch Health Companies in a note issued to investors on Thursday, May 23rd. Zacks Research analyst R. Department now expects that the company will post earnings of $0.86 per share […]

Bausch Health Companies (NYSE:BHC) Stock Rating Upgraded by StockNews com

StockNews.com upgraded shares of Bausch Health Companies (NYSE:BHC – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning. Several other research analysts have also recently commented on the stock. Jefferies Financial Group lowered their price target on shares of Bausch Health Companies from $16.00 to $14.00 and […]

Piper Sandler Boosts Bausch Health Companies (NYSE:BHC) Price Target to $9 00

Bausch Health Companies (NYSE:BHC – Get Free Report) had its price objective hoisted by analysts at Piper Sandler from $7.00 to $9.00 in a research note issued to investors on Monday, BayStreet.CA reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s price objective indicates a potential upside of 2.27% from the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.